Hildinger M - Search Results

1

Membrane-anchored peptide inhibits human immunodeficiency virus entry.

Hildinger M, Dittmar MT, Schult-Dietrich P, Fehse B, Schnierle BS, Thaler S, Stiegler G, Welker R, von Laer D. Hildinger M, et al. J Virol. 2001 Mar;75(6):3038-42. doi: 10.1128/JVI.75.6.3038-3042.2001. J Virol. 2001. PMID: 11222732 Free PMC article.

2

Lack of superinfection interference in retroviral vector producer cells.

Vogt B, Roscher S, Abel B, Hildinger M, Lamarre A, Baum C, von Laer D. Vogt B, et al. Among authors: hildinger m. Hum Gene Ther. 2001 Mar 1;12(4):359-65. doi: 10.1089/10430340150503984. Hum Gene Ther. 2001. PMID: 11242528

3

Dominant selection of hematopoietic progenitor cells with retroviral MDR1 co-expression vectors.

Hildinger M, Fehse B, Hegewisch-Becker S, John J, Rafferty JR, Ostertag W, Baum C. Hildinger M, et al. Hum Gene Ther. 1998 Jan 1;9(1):33-42. doi: 10.1089/hum.1998.9.1-33. Hum Gene Ther. 1998. PMID: 9458240

4

Bicistronic retroviral vectors for combining myeloprotection with cell-surface marking.

Hildinger M, Schilz A, Eckert HG, Bohn W, Fehse B, Zander A, Ostertag W, Baum C. Hildinger M, et al. Gene Ther. 1999 Jul;6(7):1222-30. doi: 10.1038/sj.gt.3300942. Gene Ther. 1999. PMID: 10455430

5

Design of 5' untranslated sequences in retroviral vectors developed for medical use.

Hildinger M, Abel KL, Ostertag W, Baum C. Hildinger M, et al. J Virol. 1999 May;73(5):4083-9. doi: 10.1128/JVI.73.5.4083-4089.1999. J Virol. 1999. PMID: 10196304 Free PMC article.

6

cis-Active elements of Friend spleen focus-forming virus: from disease induction to disease prevention.

Baum C, Hunt N, Hildinger M, Eckert HG, Zaehres H, Richters A, John J, Löhler J, Ostertag W. Baum C, et al. Among authors: hildinger m. Acta Haematol. 1998;99(3):156-64. doi: 10.1159/000040830. Acta Haematol. 1998. PMID: 9587397

7

Context dependence of different modules for posttranscriptional enhancement of gene expression from retroviral vectors.

Schambach A, Wodrich H, Hildinger M, Bohne J, Kräusslich HG, Baum C. Schambach A, et al. Among authors: hildinger m. Mol Ther. 2000 Nov;2(5):435-45. doi: 10.1006/mthe.2000.0191. Mol Ther. 2000. PMID: 11082317 Free article.

8

Hybrid vectors based on adeno-associated virus serotypes 2 and 5 for muscle-directed gene transfer.

Hildinger M, Auricchio A, Gao G, Wang L, Chirmule N, Wilson JM. Hildinger M, et al. J Virol. 2001 Jul;75(13):6199-203. doi: 10.1128/JVI.75.13.6199-6203.2001. J Virol. 2001. PMID: 11390622 Free PMC article.

9

Improved retroviral vectors for hematopoietic stem cell protection and in vivo selection.

Baum C, Eckert HG, Stockschläder M, Just U, Hegewisch-Becker S, Hildinger M, Uhde A, John J, Ostertag W. Baum C, et al. Among authors: hildinger m. J Hematother. 1996 Aug;5(4):323-9. doi: 10.1089/scd.1.1996.5.323. J Hematother. 1996. PMID: 8877707 Review.

10

FMEV vectors: both retroviral long terminal repeat and leader are important for high expression in transduced hematopoietic cells.

Hildinger M, Eckert HG, Schilz AJ, John J, Ostertag W, Baum C. Hildinger M, et al. Gene Ther. 1998 Nov;5(11):1575-9. doi: 10.1038/sj.gt.3300759. Gene Ther. 1998. PMID: 9930313

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

41 results

Search Page

Filters